These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27602759)

  • 1. Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.
    Qu Z; Cui J; Harata-Lee Y; Aung TN; Feng Q; Raison JM; Kortschak RD; Adelson DL
    Oncotarget; 2016 Oct; 7(40):66003-66019. PubMed ID: 27602759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms.
    Cui J; Qu Z; Harata-Lee Y; Shen H; Aung TN; Wang W; Kortschak RD; Adelson DL
    PLoS One; 2020; 15(7):e0236395. PubMed ID: 32730293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.
    Aung TN; Nourmohammadi S; Qu Z; Harata-Lee Y; Cui J; Shen HY; Yool AJ; Pukala T; Du H; Kortschak RD; Wei W; Adelson DL
    Sci Rep; 2019 Oct; 9(1):14200. PubMed ID: 31578346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
    He R; Ou S; Chen S; Ding S
    Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
    Wu X; Lu Y; Qin X
    J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Strategy for Identifying Mechanisms of Drug-drug Interaction Using Transcriptome Analysis: Compound Kushen Injection as a Proof of Principle.
    Shen H; Qu Z; Harata-Lee Y; Cui J; Aung TN; Wang W; Kortschak RD; Adelson DL
    Sci Rep; 2019 Nov; 9(1):15889. PubMed ID: 31685921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
    Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
    Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
    Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
    Front Oncol; 2022; 12():946758. PubMed ID: 36016606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer.
    Sun J; Li M; Lin T; Wang D; Chen J; Zhang Y; Mu Q; Su H; Wu N; Liu A; Yu Y; Liu Y; Wang S; Yu X; Guo J; Yu W
    Sci Rep; 2022 Mar; 12(1):4384. PubMed ID: 35288618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle, energy metabolism and DNA repair pathways in cancer cells are suppressed by Compound Kushen Injection.
    Cui J; Qu Z; Harata-Lee Y; Nwe Aung T; Shen H; Wang W; Adelson DL
    BMC Cancer; 2019 Jan; 19(1):103. PubMed ID: 30678652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
    Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
    Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis.
    Shen H; Qu Z; Harata-Lee Y; Aung TN; Cui J; Wang W; Kortschak RD; Adelson DL
    Front Oncol; 2019; 9():632. PubMed ID: 31380274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
    Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
    J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
    Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
    Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
    Liang S; Li Y; Zhang X; Guo Y; Pan S
    Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
    Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
    BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
    Jin Y; Yang Q; Liang L; Ding L; Liang Y; Zhang D; Wu B; Yang T; Liu H; Huang T; Shen H; Tu H; Pan Y; Wei Y; Yang Y; Zhou F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):277. PubMed ID: 30454068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
    Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
    J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A UPLC-Q-TOF/MS-based plasma metabolomics approach reveals the mechanism of Compound Kushen Injection-based intervention against non-small cell lung cancer in Lewis tumor-bearing mice.
    Wu H; Wang L; Zhan X; Wang B; Wu J; Zhou A
    Phytomedicine; 2020 Jun; 76():153259. PubMed ID: 32534358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.